<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="35191">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01960920</url>
  </required_header>
  <id_info>
    <org_study_id>3439/10/028</org_study_id>
    <secondary_id>2010/50150-0</secondary_id>
    <nct_id>NCT01960920</nct_id>
  </id_info>
  <brief_title>Effects of Air Pollution Exposure Reduction by Filter Mask on Heart Failure</brief_title>
  <official_title>Effects of Air Pollution Exposure Reduction by Filter Mask on Heart Failure: a Prospective Randomized Double-blind Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>InCor Heart Institute</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Fundação de Amparo à Pesquisa do Estado de São Paulo</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>LABORATÓRIO DE INSUFICIÊNCIA CARDÍACA E TRANSPLANTE INCOR/HCFMUSP</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>LABORATÓRIO DE POLUIÇÃO ATMOSFÉRICA EXPERIMENTAL (LPAE/ FMUSP).</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>InCor Heart Institute</source>
  <oversight_info>
    <authority>Brazil: Ethics Committee</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Exposure to air pollution is associated with increase in cardiovascular morbidity and
      mortality. Controlled human exposure studies have demonstrated impaired vascular function
      and heart rate variability on healthy volunteers. The aim of this study is to investigate
      the effects of reducting diesel exhaust inhalation on endothelial function, heart rate
      variability and cardiopulmonary stress testing in healthy volunteers and patients with
      chronic heart failure, by using a filter mask.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Design and setting: Double-blind randomised crossover studies in a university teaching
      hospital

      Patients: 30 patients with stable Heart Failure (NYHA I-III) and 10 healthy volunteers

      Interventions: All 40 subjects will be exposed to dilute diesel exhaust (PM2.5 of 300
      mg/m3), filtered diesel exhaust (filter mask), or filtered air

      Main outcome measures: Endothelial function, heart rate variability, cardiopulmonary
      variables during a six-minute walking test and blood samples for inflammatory factors
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>February 2013</start_date>
  <completion_date type="Anticipated">January 2015</completion_date>
  <primary_completion_date type="Anticipated">June 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Intervention Model: Crossover Assignment, Masking: Double Blind (Subject, Caregiver, Outcomes Assessor)</study_design>
  <primary_outcome>
    <measure>Endothelial Function</measure>
    <time_frame>six months</time_frame>
    <safety_issue>Yes</safety_issue>
    <description>Endothelial function assessment is based on an endothelially mediated arterial response at the distal phalanx of a finger, in response to a five-minute occlusion of the brachial artery. Arterial stiffness is assessed by a finger plethysmographic probe.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Heart rate variability</measure>
    <time_frame>six months</time_frame>
    <safety_issue>Yes</safety_issue>
    <description>Heart rate variability (HRV) analysis attempts to assess cardiac autonomic regulation through quantification of sinus rhythm variability. Heart rate and beat-to-beat intervals are recorded using a frequency counter Polar Electro Oy - 800 model, interfaced to a microcomputer, and assessed using standard time domain analysis.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Inflammatory Markers</measure>
    <time_frame>12 months</time_frame>
    <safety_issue>Yes</safety_issue>
    <description>After each exposure, we collected blood samples for inflammatory variables—including circulating leukocytes, serum C-reactive protein, B-type natriuretic peptide, Troponin and Catecholamines.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cardiopulmonary Stress Testing</measure>
    <time_frame>Six months</time_frame>
    <safety_issue>Yes</safety_issue>
    <description>Exercise testing is performed on a treadmill using a modified Naughton protocol and the 6 minute walk test. Ventilation, oxygen uptake, and carbon dioxide production are monitored continuously using a respiratory mass spectrometer.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">40</enrollment>
  <condition>Exposure to Pollution</condition>
  <condition>Heart Failure</condition>
  <arm_group>
    <arm_group_label>Healthy Volunteers</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Dilute diesel exhaust Filtered diesel exhaust Filtered air</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Heart Failure patients</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Dilute diesel exhaust Filtered diesel exhaust Filtered air</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Filtered diesel exhaust</intervention_name>
    <description>Filter Mask - air pollution reduction</description>
    <arm_group_label>Healthy Volunteers</arm_group_label>
    <arm_group_label>Heart Failure patients</arm_group_label>
    <other_name>Filter Mask 8812 (www.3m.com.br)</other_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Dilute diesel exhaust</intervention_name>
    <description>Diesel Exhaust Inhalation</description>
    <arm_group_label>Healthy Volunteers</arm_group_label>
    <arm_group_label>Heart Failure patients</arm_group_label>
    <other_name>Diesel Generator Toyama TD-2500 C, www.toyama.com.br</other_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Filtered air</intervention_name>
    <description>No pollution and no filter mask</description>
    <arm_group_label>Healthy Volunteers</arm_group_label>
    <arm_group_label>Heart Failure patients</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  NYHA I-III;

          -  Left Ventricle Ejection Fraction  &lt; 50%;

          -  Clinical condition stable for more than three months prior to the randomization;

        Exclusion Criteria:

          -  Severe arterial hypertension;

          -  Severe Pulmonary disease;

          -  Patients with pace-markers;

          -  Patients with constrictive pericarditis;

          -  Severe chronic kidney disease;

          -  Patients with pulmonary hypertension;

          -  Stroke within the last six months;

          -  Severe hepatic disease;

          -  Patients with musculoskeletal limitations to exercise;

          -  Patients with cardiac cachexia.
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Edimar A Bocchi, pHD</last_name>
    <role>Study Chair</role>
    <affiliation>Heart Failure Lab. Coordinator</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Jefferson L Vieira, MD</last_name>
    <phone>55 (11) 988133085</phone>
    <email>jefvieira@yahoo.com.br</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Edimar A Bocchi, pHD</last_name>
    <phone>55 (11) 997081692</phone>
    <email>dcledimar@incor.usp.br</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Heart Failure Lab. Incor HCFMUSP</name>
      <address>
        <city>São Paulo</city>
        <zip>05403900</zip>
        <country>Brazil</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jefferson L Vieira, MD</last_name>
      <phone>55(11)988133085</phone>
      <email>jefvieira@yahoo.com.br</email>
    </contact>
    <investigator>
      <last_name>Edimar A Bocchi, pHD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Brazil</country>
  </location_countries>
  <verification_date>October 2013</verification_date>
  <lastchanged_date>October 9, 2013</lastchanged_date>
  <firstreceived_date>October 9, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>InCor Heart Institute</investigator_affiliation>
    <investigator_full_name>Jefferson Luis Vieira</investigator_full_name>
    <investigator_title>MD</investigator_title>
  </responsible_party>
  <keyword>Air Pollution</keyword>
  <keyword>Heart Failure</keyword>
  <keyword>Endothelium</keyword>
  <keyword>Autonomic Dysfunction</keyword>
  <keyword>Cardiopulmonary Exercise Test</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Heart Failure</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
